Related Experiment Videos
Gastrointestinal leiomyosarcoma in 14 dogs
Michele Cohen1, Gerald S Post, James C Wright
1Department of Medicine and Surgery, The Animal Medical Center Auburn University, Auburn, AL 36849-5523, USA. cohenmi@vetmed.auburn.edu
Journal of Veterinary Internal Medicine
|February 5, 2003
Summary
Surgical removal of intestinal leiomyosarcoma in dogs can lead to long-term survival. Even with metastasis, dogs with intestinal leiomyosarcoma experienced significant survival times post-surgery.
Area of Science:
- Veterinary Medicine
- Canine Oncology
- Surgical Oncology
Background:
- Intestinal leiomyosarcoma is a notable gastrointestinal tumor in dogs.
- Understanding clinical features and survival outcomes is crucial for treatment planning.
Purpose of the Study:
- To identify clinical characteristics and survival rates in dogs with intestinal leiomyosarcoma following surgical intervention.
- To evaluate the impact of metastasis on survival in these cases.
Main Methods:
- A retrospective review of 14 dogs diagnosed with intestinal leiomyosarcoma over a 5-year period.
- Analysis of clinical signs, surgical outcomes, and survival data.
Main Results:
- Common clinical signs included anemia, hypoglycemia, polyuria, and polydipsia.
- Median survival for dogs surviving the postoperative period was 21.3 months (0.1-72.5 months).
- One- and 2-year survival rates were 75% and 66%, respectively. Dogs with metastasis had a mean survival of 21.7 months (4.2-41.5 months).
Conclusions:
- Surgical excision of intestinal leiomyosarcoma can result in long-term survival for canine patients.
- Histologically confirmed metastasis at surgery does not preclude a favorable long-term prognosis.